{"id":2060,"date":"2026-06-02T16:14:32","date_gmt":"2026-06-02T21:14:32","guid":{"rendered":"https:\/\/global-pharma.com.co\/?p=2060"},"modified":"2026-06-03T10:39:48","modified_gmt":"2026-06-03T15:39:48","slug":"terapia-radioligandos-cancer-prostata","status":"publish","type":"post","link":"https:\/\/global-pharma.com.co\/en\/terapia-radioligandos-cancer-prostata\/","title":{"rendered":""},"content":{"rendered":"<h3 class=\"wp-block-heading\"><strong>Novartis ampl\u00eda las fronteras en el tratamiento del c\u00e1ncer de pr\u00f3stata con medicina de precisi\u00f3n<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">La oncolog\u00eda global est\u00e1 experimentando un cambio de paradigma definitivo hacia tratamientos m\u00e1s espec\u00edficos, eficientes y personalizados. En este escenario de innovaci\u00f3n, Novartis ha consolidado su liderazgo al expandir el alcance de la terapia con radioligandos (RLT), estableciendo esta tecnolog\u00eda de vanguardia como el nuevo est\u00e1ndar cl\u00ednico para combatir el c\u00e1ncer de pr\u00f3stata metast\u00e1sico. Esta evoluci\u00f3n responde a la urgente necesidad m\u00e9dica de enfrentar una patolog\u00eda compleja, caracterizada por una alta capacidad de adaptaci\u00f3n celular y por desarrollar resistencia biol\u00f3gica frente a las opciones terap\u00e9uticas tradicionales.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">El n\u00facleo de esta estrategia cient\u00edfica se fundamenta en la intervenci\u00f3n temprana y en el despliegue de un portafolio diversificado que actualmente supera los 30 activos de alto valor en diferentes fases de desarrollo cl\u00ednico. Al dirigir la radiaci\u00f3n de manera exacta a las c\u00e9lulas tumorales que expresan prote\u00ednas espec\u00edficas, este mecanismo minimiza el impacto en los tejidos sanos circundantes. Esto abre alternativas reales y esperanzadoras para aquellos pacientes cuya enfermedad ha progresado o ha dejado de responder por completo a los bloqueos hormonales y a las quimioterapias convencionales.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">El avance hacia la medicina hiper-dirigida y el uso de nuevas plataformas basadas en actinio para tumores s\u00f3lidos plantean, al mismo tiempo, un desaf\u00edo operativo y de abastecimiento sin precedentes para la industria farmac\u00e9utica. La producci\u00f3n de medicamentos oncol\u00f3gicos de \u00faltima generaci\u00f3n exige el uso de compuestos qu\u00edmicos intermedios y principios activos (APIs) con perfiles anal\u00edticos de pureza absoluta. Asimismo, requiere una sincronizaci\u00f3n log\u00edstica impecable y un control t\u00e9rmico estricto, dado que el tiempo de vida \u00fatil y la estabilidad molecular de estos biol\u00f3gicos son sumamente limitados desde su fabricaci\u00f3n hasta su aplicaci\u00f3n en la cl\u00ednica.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Frenar la adaptaci\u00f3n del tumor antes de que desarrolle mecanismos de defensa es la clave para transformar los indicadores de supervivencia global y redefinir el futuro de la salud p\u00fablica. La comunidad cient\u00edfica y los laboratorios enfocan ahora sus esfuerzos en la transici\u00f3n hacia esta metodolog\u00eda de precisi\u00f3n anticipada, asegurando que los nuevos dise\u00f1os de investigaci\u00f3n cuenten con la solidez metodol\u00f3gica necesaria para consolidar estas mol\u00e9culas como soluciones comerciales seguras, accesibles y altamente eficaces en el mercado global.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Fuente: https:\/\/www.enfarma.lat\/index.php\/noticias\/12762-novartis-amplia-fronteras-del-tratamiento-del-cancer-de-prostata<\/p>","protected":false},"excerpt":{"rendered":"<p>Novartis ampl\u00eda las fronteras en el tratamiento del c\u00e1ncer de pr\u00f3stata con medicina de precisi\u00f3n La oncolog\u00eda global est\u00e1 experimentando un cambio de paradigma definitivo hacia tratamientos m\u00e1s espec\u00edficos, eficientes y personalizados. En este escenario de innovaci\u00f3n, Novartis ha consolidado su liderazgo al expandir el alcance de la terapia con radioligandos (RLT), estableciendo esta tecnolog\u00eda [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":2061,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_joinchat":[],"footnotes":""},"categories":[6],"tags":[],"class_list":["post-2060","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>&#8226; Global Pharma &amp; Logistic S.A.S.<\/title>\n<meta name=\"description\" content=\"Descubre c\u00f3mo la terapia con radioligandos de Novartis redefine el tratamiento del c\u00e1ncer de pr\u00f3stata metast\u00e1sico mediante medicina de precisi\u00f3n.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/global-pharma.com.co\/en\/terapia-radioligandos-cancer-prostata\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"&#8226; Global Pharma &amp; Logistic S.A.S.\" \/>\n<meta property=\"og:description\" content=\"Descubre c\u00f3mo la terapia con radioligandos de Novartis redefine el tratamiento del c\u00e1ncer de pr\u00f3stata metast\u00e1sico mediante medicina de precisi\u00f3n.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/global-pharma.com.co\/en\/terapia-radioligandos-cancer-prostata\/\" \/>\n<meta property=\"og:site_name\" content=\"Global Pharma &amp; Logistic S.A.S.\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-02T21:14:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-03T15:39:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2026\/06\/Presentacion-Comercial-Global-Pharma-Logistic.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Mar\u00eda Camila Sanchez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mar\u00eda Camila Sanchez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/terapia-radioligandos-cancer-prostata\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/terapia-radioligandos-cancer-prostata\\\/\"},\"author\":{\"name\":\"Mar\u00eda Camila Sanchez\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#\\\/schema\\\/person\\\/912625696b849a3374bc496e1df87a7c\"},\"headline\":\"No title\",\"datePublished\":\"2026-06-02T21:14:32+00:00\",\"dateModified\":\"2026-06-03T15:39:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/terapia-radioligandos-cancer-prostata\\\/\"},\"wordCount\":425,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/terapia-radioligandos-cancer-prostata\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/global-pharma.com.co\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Presentacion-Comercial-Global-Pharma-Logistic.png\",\"articleSection\":[\"Blog\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/global-pharma.com.co\\\/terapia-radioligandos-cancer-prostata\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/terapia-radioligandos-cancer-prostata\\\/\",\"url\":\"https:\\\/\\\/global-pharma.com.co\\\/terapia-radioligandos-cancer-prostata\\\/\",\"name\":\"&#8226; Global Pharma &amp; Logistic S.A.S.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/terapia-radioligandos-cancer-prostata\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/terapia-radioligandos-cancer-prostata\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/global-pharma.com.co\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Presentacion-Comercial-Global-Pharma-Logistic.png\",\"datePublished\":\"2026-06-02T21:14:32+00:00\",\"dateModified\":\"2026-06-03T15:39:48+00:00\",\"description\":\"Descubre c\u00f3mo la terapia con radioligandos de Novartis redefine el tratamiento del c\u00e1ncer de pr\u00f3stata metast\u00e1sico mediante medicina de precisi\u00f3n.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/global-pharma.com.co\\\/terapia-radioligandos-cancer-prostata\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/terapia-radioligandos-cancer-prostata\\\/#primaryimage\",\"url\":\"https:\\\/\\\/global-pharma.com.co\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Presentacion-Comercial-Global-Pharma-Logistic.png\",\"contentUrl\":\"https:\\\/\\\/global-pharma.com.co\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Presentacion-Comercial-Global-Pharma-Logistic.png\",\"width\":1920,\"height\":1080},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#website\",\"url\":\"https:\\\/\\\/global-pharma.com.co\\\/\",\"name\":\"Distribuidor de materias primas farmac\u00e9uticas en Colombia.\",\"description\":\"Principios Activos y Materias Primas en Colombia\",\"publisher\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/global-pharma.com.co\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#organization\",\"name\":\"Global Pharma & Logistic S.A.S.\",\"alternateName\":\"Global Pharma & Logistic S.A.S.\",\"url\":\"https:\\\/\\\/global-pharma.com.co\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/global-pharma.com.co\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/LOGO-COMPLETO2-02.jpg\",\"contentUrl\":\"https:\\\/\\\/global-pharma.com.co\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/LOGO-COMPLETO2-02.jpg\",\"width\":2133,\"height\":2133,\"caption\":\"Global Pharma & Logistic S.A.S.\"},\"image\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/51710617\\\/admin\\\/dashboard\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#\\\/schema\\\/person\\\/912625696b849a3374bc496e1df87a7c\",\"name\":\"Mar\u00eda Camila Sanchez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0329561f75938cb23698a3fea3fb2b239761b6609e52728bd3aef6667c8eecb3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0329561f75938cb23698a3fea3fb2b239761b6609e52728bd3aef6667c8eecb3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0329561f75938cb23698a3fea3fb2b239761b6609e52728bd3aef6667c8eecb3?s=96&d=mm&r=g\",\"caption\":\"Mar\u00eda Camila Sanchez\"},\"url\":\"https:\\\/\\\/global-pharma.com.co\\\/en\\\/author\\\/maria-sanchez\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"&#8226; Global Pharma &amp; Logistic S.A.S.","description":"Descubre c\u00f3mo la terapia con radioligandos de Novartis redefine el tratamiento del c\u00e1ncer de pr\u00f3stata metast\u00e1sico mediante medicina de precisi\u00f3n.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/global-pharma.com.co\/en\/terapia-radioligandos-cancer-prostata\/","og_locale":"en_US","og_type":"article","og_title":"&#8226; Global Pharma &amp; Logistic S.A.S.","og_description":"Descubre c\u00f3mo la terapia con radioligandos de Novartis redefine el tratamiento del c\u00e1ncer de pr\u00f3stata metast\u00e1sico mediante medicina de precisi\u00f3n.","og_url":"https:\/\/global-pharma.com.co\/en\/terapia-radioligandos-cancer-prostata\/","og_site_name":"Global Pharma &amp; Logistic S.A.S.","article_published_time":"2026-06-02T21:14:32+00:00","article_modified_time":"2026-06-03T15:39:48+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2026\/06\/Presentacion-Comercial-Global-Pharma-Logistic.png","type":"image\/png"}],"author":"Mar\u00eda Camila Sanchez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Mar\u00eda Camila Sanchez","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/global-pharma.com.co\/terapia-radioligandos-cancer-prostata\/#article","isPartOf":{"@id":"https:\/\/global-pharma.com.co\/terapia-radioligandos-cancer-prostata\/"},"author":{"name":"Mar\u00eda Camila Sanchez","@id":"https:\/\/global-pharma.com.co\/#\/schema\/person\/912625696b849a3374bc496e1df87a7c"},"headline":"No title","datePublished":"2026-06-02T21:14:32+00:00","dateModified":"2026-06-03T15:39:48+00:00","mainEntityOfPage":{"@id":"https:\/\/global-pharma.com.co\/terapia-radioligandos-cancer-prostata\/"},"wordCount":425,"commentCount":0,"publisher":{"@id":"https:\/\/global-pharma.com.co\/#organization"},"image":{"@id":"https:\/\/global-pharma.com.co\/terapia-radioligandos-cancer-prostata\/#primaryimage"},"thumbnailUrl":"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2026\/06\/Presentacion-Comercial-Global-Pharma-Logistic.png","articleSection":["Blog"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/global-pharma.com.co\/terapia-radioligandos-cancer-prostata\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/global-pharma.com.co\/terapia-radioligandos-cancer-prostata\/","url":"https:\/\/global-pharma.com.co\/terapia-radioligandos-cancer-prostata\/","name":"&#8226; Global Pharma &amp; Logistic S.A.S.","isPartOf":{"@id":"https:\/\/global-pharma.com.co\/#website"},"primaryImageOfPage":{"@id":"https:\/\/global-pharma.com.co\/terapia-radioligandos-cancer-prostata\/#primaryimage"},"image":{"@id":"https:\/\/global-pharma.com.co\/terapia-radioligandos-cancer-prostata\/#primaryimage"},"thumbnailUrl":"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2026\/06\/Presentacion-Comercial-Global-Pharma-Logistic.png","datePublished":"2026-06-02T21:14:32+00:00","dateModified":"2026-06-03T15:39:48+00:00","description":"Descubre c\u00f3mo la terapia con radioligandos de Novartis redefine el tratamiento del c\u00e1ncer de pr\u00f3stata metast\u00e1sico mediante medicina de precisi\u00f3n.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/global-pharma.com.co\/terapia-radioligandos-cancer-prostata\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/global-pharma.com.co\/terapia-radioligandos-cancer-prostata\/#primaryimage","url":"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2026\/06\/Presentacion-Comercial-Global-Pharma-Logistic.png","contentUrl":"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2026\/06\/Presentacion-Comercial-Global-Pharma-Logistic.png","width":1920,"height":1080},{"@type":"WebSite","@id":"https:\/\/global-pharma.com.co\/#website","url":"https:\/\/global-pharma.com.co\/","name":"Distribuidor de materias primas farmac\u00e9uticas en Colombia.","description":"Principios Activos y Materias Primas en Colombia","publisher":{"@id":"https:\/\/global-pharma.com.co\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/global-pharma.com.co\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/global-pharma.com.co\/#organization","name":"Global Pharma & Logistic S.A.S.","alternateName":"Global Pharma & Logistic S.A.S.","url":"https:\/\/global-pharma.com.co\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/global-pharma.com.co\/#\/schema\/logo\/image\/","url":"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2025\/08\/LOGO-COMPLETO2-02.jpg","contentUrl":"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2025\/08\/LOGO-COMPLETO2-02.jpg","width":2133,"height":2133,"caption":"Global Pharma & Logistic S.A.S."},"image":{"@id":"https:\/\/global-pharma.com.co\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/51710617\/admin\/dashboard\/"]},{"@type":"Person","@id":"https:\/\/global-pharma.com.co\/#\/schema\/person\/912625696b849a3374bc496e1df87a7c","name":"Mar\u00eda Camila Sanchez","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/0329561f75938cb23698a3fea3fb2b239761b6609e52728bd3aef6667c8eecb3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0329561f75938cb23698a3fea3fb2b239761b6609e52728bd3aef6667c8eecb3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0329561f75938cb23698a3fea3fb2b239761b6609e52728bd3aef6667c8eecb3?s=96&d=mm&r=g","caption":"Mar\u00eda Camila Sanchez"},"url":"https:\/\/global-pharma.com.co\/en\/author\/maria-sanchez\/"}]}},"_links":{"self":[{"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/posts\/2060","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/comments?post=2060"}],"version-history":[{"count":3,"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/posts\/2060\/revisions"}],"predecessor-version":[{"id":2071,"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/posts\/2060\/revisions\/2071"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/media\/2061"}],"wp:attachment":[{"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/media?parent=2060"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/categories?post=2060"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/tags?post=2060"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}